🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy and safety and population PK of HMS5552 a...
Status
Completed
Location
Hua Medicine Limited
Start Date
2017-07-18
Trial ID
NCT03173391
A total of 30 subjects will be recruited 15 with intermediate hyperglycemia...
Status
Not Yet Recruiting
Location
Phase 1 Clinical Trial Centre
Start Date
2025-04-02
Trial ID
NCT06671340
Treatments Being Tested
This crossover study investigates the safety, tolerability, pharmacokinetic...
Status
Completed
Location
Peking University Third Hospital
Start Date
2019-08-27
Trial ID
NCT03973515
Treatments Being Tested
The purpose of this study is to help answer the following questions: * To ...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-12
Trial ID
NCT01024244
The purpose of this study is to determine (1) whether ZYGK1 is safe and wel...
Status
Suspended
Location
Clinical R&D, Zydus Research Center, Cadila Healthcare Limited, NH No.8, Moraiya
Start Date
2011-12
Trial ID
NCT01472809
This is a Phase 1, open-label, sequential, multiple-dose, drug interaction ...
Status
Completed
Location
Frontage Clinical Services Inc.
Start Date
2019-01-31
Trial ID
NCT03790839
Treatments Being Tested
This is a Phase 1, open-label, sequential, multiple-dose, drug interaction ...
Status
Completed
Location
Frontage Clinical Services Inc.
Start Date
2019-04-18
Trial ID
NCT03790787
Treatments Being Tested
Evaluating a novel, allosteric glucokinase activator in monogenic diabetes ...
Status
Recruiting
Location
3M, Diabetes and Endocrine Research Center
Start Date
2025-04-30
Trial ID
NCT06976658
Treatments Being Tested
The objectives of this study is to determine the safety, tolerability, phar...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02077452